Equities analysts predict that Merit Medical Systems, Inc. (NASDAQ:MMSI) will report earnings of $0.32 per share for the current fiscal quarter, according to Zacks Investment Research. Four analysts have made estimates for Merit Medical Systems’ earnings, with estimates ranging from $0.30 to $0.33. Merit Medical Systems reported earnings per share of $0.31 during the same quarter last year, which would suggest a positive year-over-year growth rate of 3.2%. The company is scheduled to issue its next earnings report on Tuesday, February 20th.

According to Zacks, analysts expect that Merit Medical Systems will report full year earnings of $1.27 per share for the current fiscal year, with EPS estimates ranging from $1.25 to $1.28. For the next fiscal year, analysts forecast that the business will post earnings of $1.47 per share, with EPS estimates ranging from $1.42 to $1.60. Zacks’ EPS calculations are an average based on a survey of sell-side analysts that follow Merit Medical Systems.

Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings results on Wednesday, October 25th. The medical instruments supplier reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.30 by $0.02. Merit Medical Systems had a net margin of 4.06% and a return on equity of 9.86%. The company had revenue of $179.30 million for the quarter, compared to the consensus estimate of $181.28 million. During the same period in the previous year, the firm earned $0.26 EPS. Merit Medical Systems’s revenue was up 14.2% on a year-over-year basis.

MMSI has been the topic of a number of research reports. Canaccord Genuity reiterated a “buy” rating and issued a $45.00 target price on shares of Merit Medical Systems in a report on Wednesday, September 6th. ValuEngine upgraded shares of Merit Medical Systems from a “hold” rating to a “buy” rating in a report on Tuesday, November 21st. SunTrust Banks set a $47.00 target price on shares of Merit Medical Systems and gave the stock a “buy” rating in a report on Thursday, November 16th. Zacks Investment Research upgraded shares of Merit Medical Systems from a “hold” rating to a “buy” rating and set a $43.00 target price on the stock in a report on Saturday, October 28th. Finally, Raymond James Financial reiterated an “outperform” rating and issued a $44.00 target price on shares of Merit Medical Systems in a report on Monday, August 28th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $43.77.

In other Merit Medical Systems news, Director Kent W. Stanger sold 670 shares of the business’s stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $42.06, for a total value of $28,180.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders have sold 5,518 shares of company stock worth $239,276 over the last ninety days. 5.00% of the stock is currently owned by insiders.

Hedge funds have recently bought and sold shares of the business. LS Investment Advisors LLC grew its position in Merit Medical Systems by 8.1% in the second quarter. LS Investment Advisors LLC now owns 3,694 shares of the medical instruments supplier’s stock worth $141,000 after acquiring an additional 277 shares in the last quarter. Advisors Asset Management Inc. grew its position in Merit Medical Systems by 28.2% in the second quarter. Advisors Asset Management Inc. now owns 3,723 shares of the medical instruments supplier’s stock worth $142,000 after acquiring an additional 820 shares in the last quarter. Ameritas Investment Partners Inc. grew its position in Merit Medical Systems by 20.9% in the second quarter. Ameritas Investment Partners Inc. now owns 4,272 shares of the medical instruments supplier’s stock worth $163,000 after acquiring an additional 738 shares in the last quarter. SG Americas Securities LLC bought a new stake in Merit Medical Systems in the third quarter worth approximately $189,000. Finally, Riverhead Capital Management LLC grew its position in Merit Medical Systems by 67.7% in the second quarter. Riverhead Capital Management LLC now owns 5,198 shares of the medical instruments supplier’s stock worth $198,000 after acquiring an additional 2,098 shares in the last quarter. 90.89% of the stock is owned by institutional investors.

Merit Medical Systems (NASDAQ:MMSI) traded up $0.60 during midday trading on Thursday, hitting $43.85. 410,222 shares of the company were exchanged, compared to its average volume of 388,315. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.78 and a quick ratio of 1.43. Merit Medical Systems has a twelve month low of $24.23 and a twelve month high of $45.50. The company has a market cap of $2,188.67, a P/E ratio of 34.33, a P/E/G ratio of 2.95 and a beta of 1.23.

TRADEMARK VIOLATION WARNING: This piece was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of United States & international copyright laws. The correct version of this piece can be read at https://www.americanbankingnews.com/2017/12/07/brokerages-anticipate-merit-medical-systems-inc-mmsi-will-post-earnings-of-0-32-per-share.html.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Get a free copy of the Zacks research report on Merit Medical Systems (MMSI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.